Compare Pfizer with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUVEN LIFESCIENCES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUVEN LIFESCIENCES PFIZER/
SUVEN LIFESCIENCES
 
P/E (TTM) x 39.0 19.2 203.0% View Chart
P/BV x 6.6 3.9 169.1% View Chart
Dividend Yield % 0.5 0.5 95.8%  

Financials

 PFIZER   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    PFIZER
Mar-19
SUVEN LIFESCIENCES
Mar-19
PFIZER/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs3,840338 1,137.1%   
Low Rs2,080169 1,227.9%   
Sales per share (Unadj.) Rs455.052.1 872.8%  
Earnings per share (Unadj.) Rs93.86.8 1,372.9%  
Cash flow per share (Unadj.) Rs109.48.6 1,276.4%  
Dividends per share (Unadj.) Rs22.501.50 1,500.0%  
Dividend yield (eoy) %0.80.6 128.5%  
Book value per share (Unadj.) Rs658.265.3 1,008.2%  
Shares outstanding (eoy) m45.75127.28 35.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.9 133.8%   
Avg P/E ratio x31.637.1 85.0%  
P/CF ratio (eoy) x27.129.6 91.5%  
Price / Book Value ratio x4.53.9 115.8%  
Dividend payout %24.022.0 109.3%   
Avg Mkt Cap Rs m135,42032,272 419.6%   
No. of employees `0002.61.1 243.2%   
Total wages/salary Rs m3,238661 489.8%   
Avg. sales/employee Rs Th7,911.46,132.2 129.0%   
Avg. wages/employee Rs Th1,230.9611.1 201.4%   
Avg. net profit/employee Rs Th1,630.7803.5 203.0%   
INCOME DATA
Net Sales Rs m20,8156,635 313.7%  
Other income Rs m1,674242 690.9%   
Total revenues Rs m22,4896,877 327.0%   
Gross profit Rs m5,7121,604 356.1%  
Depreciation Rs m714221 322.4%   
Interest Rs m7338 193.4%   
Profit before tax Rs m6,5991,587 415.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309718 321.5%   
Profit after tax Rs m4,291869 493.5%  
Gross profit margin %27.424.2 113.5%  
Effective tax rate %35.045.2 77.3%   
Net profit margin %20.613.1 157.3%  
BALANCE SHEET DATA
Current assets Rs m27,1676,232 435.9%   
Current liabilities Rs m8,9171,490 598.4%   
Net working cap to sales %87.771.5 122.7%  
Current ratio x3.04.2 72.8%  
Inventory Days Days6886 78.5%  
Debtors Days Days3083 36.4%  
Net fixed assets Rs m8,8624,043 219.2%   
Share capital Rs m458127 359.4%   
"Free" reserves Rs m29,6568,183 362.4%   
Net worth Rs m30,1138,310 362.4%   
Long term debt Rs m2518 140.4%   
Total assets Rs m39,40010,389 379.2%  
Interest coverage x91.543.1 212.3%   
Debt to equity ratio x00 38.8%  
Sales to assets ratio x0.50.6 82.7%   
Return on assets %11.18.7 126.8%  
Return on equity %14.210.5 136.2%  
Return on capital %22.119.5 113.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4285,622 7.6%   
Fx outflow Rs m7861,799 43.7%   
Net fx Rs m-3583,822 -9.4%   
CASH FLOW
From Operations Rs m978356 275.1%  
From Investments Rs m351-279 -126.1%  
From Financial Activity Rs m-1,099-225 488.0%  
Net Cashflow Rs m231-148 -155.7%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 36.5 64.9%  
Shareholders   85,207 37,287 228.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   WYETH LTD  IPCA LABS  NATCO PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Dec 13, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS